Sponsor:
Ruth O'Regan
Code:
NCT04886531
Conditions
Breast Cancer
HER2-positive Breast Cancer
ER Positive Breast Cancer
PR-Positive Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Neratinib
Letrozole (L) or Anastrozole (A)
Trastuzumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations